Ironwood Pharmaceuticals (IRWD) News Today $3.53 +0.08 (+2.32%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 4.6% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 4.6% - Here's What HappenedDecember 17 at 4:24 PM | marketbeat.comZacks Research Has Negative Outlook for IRWD FY2026 EarningsDecember 14, 2024 | americanbankingnews.comZacks Research Has Bearish Estimate for IRWD FY2026 EarningsIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities research analysts at Zacks Research reduced their FY2026 earnings estimates for shares of Ironwood Pharmaceuticals in a research note issued to investors on Tuesday, December 10th. Zacks Research analyst R. Department now forecDecember 13, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.40 Average Target Price from AnalystsDecember 12, 2024 | americanbankingnews.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 23.7% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,904,December 11, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Hodges Capital Management Inc.Hodges Capital Management Inc. trimmed its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 66.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 347,500 shares of the biotechnology company's stock after sellingDecember 9, 2024 | marketbeat.comWeiss Asset Management LP Takes Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Weiss Asset Management LP purchased a new position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 216,707 shares of the biotechnology company's stock, vDecember 9, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Sets New 52-Week Low - Here's What HappenedDecember 8, 2024 | americanbankingnews.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Moderate Buy" from AnalystsIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have giveDecember 7, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Hits New 12-Month Low - Should You Sell?Ironwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 12-Month Low - Here's What HappenedDecember 6, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Bought by Walleye Capital LLCWalleye Capital LLC lifted its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 264.2% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 280,299 shares of the biotechnology company's stock after buying an additional 20December 6, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC decreased its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 48.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 455,477 shareDecember 4, 2024 | marketbeat.comFY2024 Earnings Forecast for IRWD Issued By Zacks ResearchIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Investment analysts at Zacks Research decreased their FY2024 earnings per share (EPS) estimates for shares of Ironwood Pharmaceuticals in a research report issued on Thursday, November 28th. Zacks Research analyst R. Department now antiDecember 2, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Significant Drop in Short InterestIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) was the recipient of a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 8,570,000 shares, a drop of 21.8% from the October 31st total of 10,960,000 shares. Based on an average daily volume of 1,630,000 shares, the short-interest ratio is presently 5.3 days. Currently, 5.5% of the shares of the company are sold short.November 30, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.4% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 4.4% - What's Next?November 29, 2024 | marketbeat.comIronwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 27, 2024 | finance.yahoo.comPacer Advisors Inc. Grows Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Pacer Advisors Inc. raised its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 26.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,279,822 shares of the biotechnology company's stoNovember 22, 2024 | marketbeat.comAndrew Davis Sells 5,360 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) StockNovember 21, 2024 | insidertrades.comIronwood Pharmaceuticals (IRWD) Stock Declines Despite Industry GainsNovember 20, 2024 | gurufocus.comARMISTICE CAPITAL, LLC Acquires Significant Stake in Ironwood Pharmaceuticals IncNovember 14, 2024 | gurufocus.comGSA Capital Partners LLP Increases Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)GSA Capital Partners LLP lifted its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 194.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 351,193 shares of the biotechnology comNovember 14, 2024 | marketbeat.comIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNovember 13, 2024 | businesswire.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three haveNovember 12, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Lowered to "Buy" Rating by StockNews.comStockNews.com lowered shares of Ironwood Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a research note on Tuesday.November 12, 2024 | marketbeat.comWhat is Leerink Partnrs' Estimate for IRWD FY2024 Earnings?Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Analysts at Leerink Partnrs cut their FY2024 earnings estimates for Ironwood Pharmaceuticals in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst F. Khurshid now expects that the biotecNovember 11, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call TranscriptNovember 10, 2024 | msn.comRobeco Institutional Asset Management B.V. Increases Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Robeco Institutional Asset Management B.V. grew its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 1,293.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 380,960 shares of the biotechnology company's stock after buying an additNovember 10, 2024 | marketbeat.comPositive Outlook for Ironwood Pharmaceuticals: LINZESS Growth and Apraglutide Potential Drive Buy RatingNovember 8, 2024 | markets.businessinsider.comIronwood Pharmaceuticals Reports Q3 2024 PerformanceNovember 8, 2024 | markets.businessinsider.comIronwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Estimates By $0.07 EPSIronwood Pharmaceuticals (NASDAQ:IRWD - Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.07). The firm had revenue of $91.60 million for the quarter, compared to analyst estimates of $91.22 million. Ironwood Pharmaceuticals had a net margin of 2.30% and a negative return on equity of 6.37%. The company's quarterly revenue was down 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.12 EPS.November 8, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comIronwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Down - Time to Sell?Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Down - Time to Sell?November 7, 2024 | marketbeat.comEarnings Preview: Ironwood PharmaceuticalsNovember 6, 2024 | benzinga.comIronwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comCraig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD)November 5, 2024 | markets.businessinsider.comIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.comStockNews.com raised shares of Ironwood Pharmaceuticals from a "buy" rating to a "strong-buy" rating in a report on Monday.November 4, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Emerald Advisers LLCEmerald Advisers LLC lowered its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 41.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 456,770 shares of the biotechnology company's stock afterNovember 4, 2024 | marketbeat.comIronwood Pharmaceuticals (IRWD) Set to Announce Earnings on ThursdayIronwood Pharmaceuticals (NASDAQ:IRWD) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639955)October 31, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% Higher - Time to Buy?Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9.1% - What's Next?October 28, 2024 | marketbeat.comIronwood Pharmaceuticals Shares Rise 10% on Positive Results in Bowel Disease StudyOctober 28, 2024 | marketwatch.comIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallOctober 24, 2024 | finance.yahoo.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock, Guidance And ForecastOctober 22, 2024 | benzinga.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock, Short Interest ReportOctober 22, 2024 | benzinga.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8% - What's Next?October 21, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven analysts that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and foOctober 18, 2024 | marketbeat.comZacks Research Research Analysts Decrease Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Stock analysts at Zacks Research lowered their FY2025 earnings per share estimates for Ironwood Pharmaceuticals in a research note issued to investors on Monday, October 14th. Zacks Research analyst R. Department now forecasts that theOctober 17, 2024 | marketbeat.comWedge Capital Management L L P NC Purchases Shares of 314,843 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Wedge Capital Management L L P NC acquired a new stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 314,843 shares of the biotechnology compaOctober 17, 2024 | marketbeat.comIs Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?October 16, 2024 | msn.comQ1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by AnalystIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Research analysts at Zacks Research decreased their Q1 2025 earnings estimates for Ironwood Pharmaceuticals in a note issued to investors on Monday, October 14th. Zacks Research analyst R. Department now forecasts that the biotechnologyOctober 16, 2024 | marketbeat.com Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Secret Manhattan Project (Ad)On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just spent six months investigating this...and what I found is shocking. Click here and I’ll show you exactly how to position your money IRWD Media Mentions By Week IRWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼0.030.69▲Average Medical News Sentiment IRWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼85▲IRWD Articles Average Week Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Celldex Therapeutics News MannKind News Dynavax Technologies News BioCryst Pharmaceuticals News Novavax News Myriad Genetics News Innoviva News OPKO Health News Sangamo Therapeutics News Emergent BioSolutions News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRWD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
